ADS Annual Meeting 2019 Day One

#ADS19Boston Twitter: @AmerDelirium Facebook: @theAmericanDeliriumSociety


Welcome to Boston, Massachusetts, for the 2019 Annual Meeting of the American Delirium Society! The 3-day conference draws investigators, educators, and clinicians from all spectrums of healthcare and is truly the destination for professionals dedicated to delirium care at every level of their career. The ADS meeting is all about learning, networking, and making connections. This gathering engages a diverse group of attendees across many disciplines and countries – all dedicated to making a difference in patients across all care settings who are at risk for delirium or who develop delirium. Our 2019 Annual Meeting is larger than ever with 90 international faculty, 40 symposiums and workshops, 100 moderated posters, and 10 oral abstract sessions. We are proud to say that at ADS 2019 there will be something for everyone!

ADS Boston 2019 Conference Planning Committee:

Clay Angel MD; Andrew Auerbach MD; Leanne Boehm RN, PhD; Kristin Brooks MD, MS; Heidi Engel DPT; Timothy Girard MD, MPH; Dae Kim MD, MPH; Heidi Lindroth RN, PhD; Mark Oldham MD; Pratik Pandharipande MD, MSCI; Stephanie Rogers MD; Jane Saczynski PhD; Heidi Smith MD, MSCI.

On the eve of the 2019 Annual Meeting, the ADS Board of Directors hosted the 2019 ADS Annual Meeting Faculty Opening Reception.

Day One of the Annual Meeting began with a Mentor-Mentee and Clinical Practice Area breakfast.

Presidential Address & Recognition of Partner Organizations

John Devlin, PharmD, FCCP, FCCM

During his Presidential Address, Dr. John Devlin highlighted that over 2000 delirium related articles have been published in just the past 12 months. He proclaimed that after nearly a decade of advocacy, education, research and quality improvement, the ADS is a leader in reducing delirium around the world. At the end of the address he invited Drs Inouye, Khachurian, Rose and Barnes to feature specific initiatives.

Sharon Inouye M.D., M.P.H, representing NIDUS
Ara Khachaturian Ph.D, representing IDID: International Drive to Illuminate Delirium
Louise Rose PhD, RN, FAAN representing The Del-COrS Study
Sean Barnes M.B.A., M.D: A Primer on the Professional Role of Social Media

The Head Bone is Connected to the Body Bone: The Role of Physical Rehabilitation on Delirium in the ICU and Beyond

Plenary Presenter: Dale Needham MD, PhD

Dr. Needham championed the role of Rehabilitation and Mobility as a recommended non-pharmacological treatment for delirium. He provided evidence of the positive biological effects on cognitive functioning and the potential benefit in reducing delirium shown by recent RCTs. He asserted that the evidence is evolving with new RCTs underway, and that changes in clinical care are possible through structured QI processes. For additional ICU Rehab Solutions/Resources go to:

When Inflammation Meets Neurodegeneration: A Perfect Storm for Postoperative Delirium

Plenary Presenter: Niccolo Terrando PhD

Dr. Terrando addressed the role of inflammation in relation to neurodegeneration and how this relationship influences the development of postoperative delirium.

Exhibitor Theater: Philips Research: Towards Delirium Prevention and Detection

Thomas Falck MSc

ADS Gold Sponsor "Philips" studies whether changes in motion are indicative for delirium in ICU patients, and pursues innovative ways of improving delirium detection and management.

Symposium: Interdisciplinary Approach to Pediatric Delirium: Evolution of Models of Care with Application of Practice-Based Evidence to Optimize Brain Health

Maalobeeka Gangopadhyay MD; Stacey Williams CPNP-AC; Lara Nelson MD; D. Catherine Fuchs MD, DFAACAP; Heidi Smith MD, MSc;

Symposium: The Role of Novel Biomarkers to Evaluate Delirium Outcomes in the Critically Ill

Sophia Wang, MD; Christopher Hughes MD; Tim Girard MD, MSc; Sikandar Khan DO, MS

Oral Abstract Session: delirium in the neurologically injured

Sophie Ryan MD; Michael Reznik MD; Tamara Fong MD, PhD; Eyal Kimchi MD, PhD; Carl Zipser MD

Roundtable: Delirium Recognition and Reduction: Practices Across the Americas

Indalecio Carboni Bisso MD; Flavia Garcez MD; Roberta Esteves Vieira de Castro MD; Patricia Mesa MD; Jose Maldonado MD

Year in Review: Critical Care/Assessment/Implementation

Michelle Weckmann MD, MS; Noll Campbell PharmD; Jin Han MD, MSc; Joanna Stollings PharmD

Network for Investigation of Delirium: Unifying Scientists (NIDUS): Overview and Updates

Sharon Inouye MD, MPH; Andrew Auerbach MD, MPH; Jan Busby-Whitehead MD; Edward Marcantonio MD, SM; Sarinnapha (Fah) Vasunilashorn PhD; Richard Jones ScD; Dale Needham MD, PhD
Michael Avidan MBBCh; Tamara Fong MD PhD; Donna Fick PhD, MSN
Real life Mentor/Mentee Pair John Devlin PharmD, FCCP, FCCM and Matthew Duprey PharmD walk down the research road to Oz with NIDUS

Workshop: A Delirium Triple Threat: 3 Phenotypes, 3 Settings, and 3 Different Rehabilitation Professionals

Tara Soudant OT; Heidi Engel DPT; Deborah Ha SLP

Board of Directors RECOGNITIONs

John Devlin PharmD, FCCP, FCCM; Marianne Shaughnessy PhD CRNP, Karin Neufeld MD, MPH, and Pratik Pandharipande MD, MSCI

ADS expresses deep gratitude for retiring board members Marianne Shaughnessy PhD CRNP, Karin Neufeld MD,MPH and Pratik Pandharipande MD, MSCI.

Babar Khan MD, MS and John Devlin PharmD, FCCP, FCCM

ADS President Elect Babar Khan MD, MS recognizes ADS Current President John Devlin PharmD, FCCP, FCCM for his service this year.

Park Plaza Ballroom Luncheon

Symposium: The ABCDEF Bundle: Implementation and Application Considerations

Leanne Boehm RN, PhD; Dale Needham MD, PhD; Federico Carini MD; Nathan Brummel MD, MSc; Kirsten Fiest MD

Symposium: Utilizing Neuro-Monitoring and Neuro-Imaging Modalities to Predict Postoperative Cognitive Outcomes

"Intraoperative Sedation Monitoring and Cognitive Outcomes": Frederick Sieber MD
"Relationship between Cerebral Autoregulation Monitoring and Postoperative Outcomes": Charlie Brown MD
"Novel Neural Signal Processing Techniques to Predict Postoperative Cognitive Outcomes": Emery Brown MD, PhD
"Diffusion MRI Pre-Operatively to Predict Postoperative Outcomes- Ready for Real Time?": Michele Cavallari MD, PhD

NIDUS Oral Abstract Session #1

Zoe Tieges; Sharon Inouye MD, MPH; Tammy Hshieh MD, MPH; Deborah D'Avollo PhD, BC-ACNP, ANP; Sarinnapha (Fah) Vasunilashorn PhD

Workshop: Innovative Geriatric Programs to Facilitate Health System Delirium Reduction Programs

Emily Simmons MSN (Not pictured: Christine Waszynski DNP, APRN; Katrina Booth MD & Shari Biswal MSN)

Symposium: What Can We Learn About Recent Antipsychotic Delirium Research?

"The MIND-USA RCT": Timothy Girard MD, MSc
"The REDUCE RCT": Mark van den Boogaard PhD, RN
"How I Use Antipsychotics in the ICU": Valerie Page MBBCh
"Utilization and Safety of Antipsychotics in Hospitalized Older Adults": Dae Kim MD, MPH

Workshop: Sustaining Organization-Wide Delirium Recognition & Intervention Programs: A Tale of Four Centers

Kristen Brooks MD, MS; Stephanie Rogers MD, MS; Benjamin Kalivas MD; Leo Pozuelo MD, FACP

NIDUS Oral Abstract Session #2

Ariba Khan MD, MPH; Eyal Kimchi MD, PhD; Towia Libermann PhD; Matthew Duprey PharmD

Symposium: Addressing the Clinical Challenges of Delirium Management in Palliative Care Settings

Shirley Bush MBBS; Peter Lawlor MB, MMedSc; Meera Agar MBBS, PhD; Anne Marie Hosie PhD, RN

Symposium: Novel Biomarkers for Predicting Postoperative Delirium Incidence and Progression of Cognitive Decline

"Novel Biomarkers to Predict Delirium and other Perioperative Neurocognitive Disorders following Anaesthesia and Surgery": Lis Evered MBiostat, MSc, PhD
"Biomarkers of Postoperative Delirium in Hip Fracture": Esther Oh MD, PhD
"Gene-Protein Interactions of Apolipoprotein E and Catecho-o-Methyltransferase Genotypes with C-Reactive Protein on Postoperative Delirium": Sarinnapha (Fah) Vasunilashorn PhD

Oral Abstract Session: Intensive Care Unit - #1

Wolfgang Ganglberger MSc; Paul Rood MSc; Karla Krewulak PhD; Carol Chan MD

Workshop: Delirium vs. Encephalopathy: Optimizing Definitions, Documentation, and Billing

Clay Angel MD; Kristen Brooks MD; Arjen Slooter MD, PhD

Poster Viewing and Reception

Sean Barnes MD discussing his poster
Park Plaza Poster Reception

Accreditation Statement

Physicians / Nurses / Pharmacists

In support of improving patient care, this activity has been planned and implemented by Amedco, LLC and American Delirium Society. Amedc,o LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

Amedco, LLC designates this live activity for a maximum of 20.75 AMA PRA Category 1 CreditsTM for physicians and 20.75 contact hours for nurses and 20.75 knowledge/application/practice-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.

NOTE: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.

conference partners:

gold sponsors:

silver sponsors:

Contact: info@americandeliriumsociety.org


Created with an image by daniela de gol - "untitled image"

Report Abuse

If you feel that this video content violates the Adobe Terms of Use, you may report this content by filling out this quick form.

To report a copyright violation, please follow the DMCA section in the Terms of Use.